Curia Announces Expansions to Global Network of Sterile Fill-Finish Sites
Curia, a contract research, development, and manufacturing organization (CDMO), recently announced expansion plans for its Glasgow, UK, facility and provided updates on the ongoing expansion in Albuquerque, NM, US.
Curia’s Glasgow facility is expanding to include an isolator-based vial filling line and additional lyophilizer, more than doubling its GMP batch size and increasing capacity to 20,000 vials. The new setup will enable faster, lossless filling and greater scalability for clinical and potential commercial production. The facility will maintain normal operations during the expansion.
“Our investment in Glasgow underscores Curia’s commitment to being an end-to-end partner,” said Philip Macnabb, CEO of Curia. “So much innovation exists in the early stages of clinical development, and Curia is eager to meet the growing demand for increased capacity for our clinical-stage clients.”
The Glasgow expansion complements a $200 million multi-year investment at Curia’s Albuquerque facility, which is adding over 70,000 square feet and two isolated filling lines. These will increase phase III clinical and commercial capacity. A VarioSys Flex Line for small-scale biologics and non-potent molecules is currently being commissioned, while a high-speed vial line with freeze dryers and automated inspection is set to begin commissioning in Q3 2025.
“Increased demand for GLP-1 agonists, new biologic drugs, coupled with on-going supply chain reviews by our customers make this an ideal time for this capacity In Albuquerque to come on-line,” Macnabb went on to say. “Curia is ideally suited to help our clients meet all of these challenges with our multiple U.S. manufacturing facilities, supply chain expertise and readily available capacity.”
Curia’s global network of sterile fill-finish facilities also includes clinical development and manufacturing capabilities in Camarillo and Thousand Oaks, CA, US and commercial and clinical manufacturing capabilities in Burlington, MA, US.
